期刊文献+

细菌耐药性监测与抗菌药物应用分析 被引量:2

Surveillance of bacterial resistance and analysis of antibiotics application
原文传递
导出
摘要 目的了解临床分离病原菌的耐药性及常见抗菌药物的使用,为临床合理使用抗菌药物提供参考。方法对2011年临床分离病原菌采用纸片扩散法进行药敏试验,采用限定日剂量(DDD)、用药频度(DDDs)等指标,对抗菌药物的应用进行分析。结果共检出病原菌5113株,革兰阳性菌占17.7%,革兰阴性菌占82.3%;耐甲氧西林金黄色葡萄球菌(MRSA)、耐碳青霉烯类鲍氏不动杆菌、耐碳青霉烯类铜绿假单胞菌、耐碳青霉烯类肠杆菌,分别占该菌种的21.3%、33.8%、17.7%、1.0%;左氧氟沙星和头孢吡肟DDDs排序一直保持在前2位,美罗培南、亚胺培南DDDs排序逐渐后退直至停用,氨曲南DDDs每季度逐渐增加;氨苄西林/舒巴坦DDDs后3个季度平均比第一季度下降73.6%;头孢噻肟DDDs第四季度比前3个季度平均下降86.4%;全年米诺环素DDDs最低,为28个治疗日;哌拉西林/他唑巴坦的日均费用最高,为798.0元/d。结论鲍氏不动杆菌、铜绿假单胞菌对美罗培南、亚胺培南耐药率的变化趋势与用药频度的变化趋势一致;铜绿假单胞菌耐药率的变化趋势与氨曲南用药频度的变化趋势相反,各种抗菌药物使用的变化对医院内细菌的耐药率有较大影响,应加强管理,合理使用抗菌药物,延缓细菌耐药产生。 OBJECTIVE To understand the drug resistance of the clinical pathogens and the use of common antibiotics so as to provide basis for the reasonable use of antibiotics.METHODS The application of antibacterial drugs was analyzed through disk diffusion method for antimicrobial susceptibility testing of the clinical pathogens isolated in 2011,the utilization of antibacterial drugs was analyzed with DDD and DDDs as the indexes.RESULTS A total of 5113 strains of pathogens were detected.The gram-positive bacteria accounted for 17.7%,the gram-negative bacteria accounted for 82.3%.Methicillin-resistant Staphylococcus aureus(MRSA),carbapenem-resistant Acinetobacter baumannii,carbapenem-resistant Pseudomonas aeruginosa,and carbapenem-resistant Enterobacter accounted for 21.3%,33.8%,17.7%,and 1.0% respectively.Levofloxacin and cefepime remained as ranking the first two places of DDDs.The ranking of DDDs of meropenem and imipenem were gradually back away till the drugs being withdrawn.Aztreonam was going forward quarterly in the ranking of DDDs.In the ranking of DDDs,ampicillin/sulbactam went backward by 73.6% in the last three quarters compared with that in the first quarter.The ranking of DDDs of cefotaxime in the fourth quarter decreased by 86.4% compared with that in the first three quarters.The DDDs of minocycline hydrochloride tablets ranked the last throughout the year,which lasted only 28 treatment days.The daily expense of piperacillin/tazobactam was the highest,which reached 798 yuan per day.CONCLUSION The trend of drug resistance of A.baumannii and P.aeruginosa to meropenem and imipenem is consistent with the trend of DDDs.The trend of drug resistance of P.aeruginosa is opposite to the DDDs of aztreonam.As the use of antimicrobial agents has a great influence on the bacterial drug resistance,the management in hospital should be strengthened to make sure that the antimicrobial drugs are properly used to delay the bacterial resistance.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第8期1886-1888,共3页 Chinese Journal of Nosocomiology
关键词 细菌 耐药性监测 抗菌药物 应用分析 Bacteria Drug resistance monitoring Antibacterial drugs Application analysis
  • 相关文献

参考文献4

二级参考文献26

  • 1沈德莉,黄仲义,范瑛,孙惠丽,赵永红.抗菌药使用与金黄色葡萄球菌耐药率变化相关分析[J].药物流行病学杂志,2005,14(4):244-246. 被引量:9
  • 2王辉,陈民钧,倪语星,陈冬梅,孙自庸,陈燕,赵旺胜,邹雄,俞云松,胡志东,黄心宏,徐英春,谢秀丽,褚云卓,王倩,梅亚宁,田彬,张蓓,孔庆莲,于秀娟,潘玉红.2003—2004年中国十家教学医院革兰阴性杆菌的耐药分析[J].中华检验医学杂志,2005,28(12):1295-1303. 被引量:236
  • 3杨平满,周建英.常见多重耐药菌的耐药机制及防治对策[J].中华医院感染学杂志,2006,16(12):1434-1437. 被引量:145
  • 4Xiong ZZ,Zhu DM,Wang FA.Klebsiella pneumoniae producing three kinds of class A β -lactamases encoded by single plasmid isolated from a patient in Huashan Hospital,Shanghai,China[J].Int J Antimicrob Agents,2004,23(3):262-267.
  • 5朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:73
  • 6Williams R J, Ryan M J.Surveillance of antimicrobial resistance-an international perspective[J]. BMJ, 1998, 317 651.
  • 7Prema S S, John F T, Philip E C, et al. Chromosomal DNA restriction endonuclease digestion patterns of b-lactamase- producing Enterococcus faecalis isolates collectedfrom a single hospital over a 7-year period[J]. J Clin Microbiol, 1996, (8): 1892-1896.
  • 8zillich A J, Sutherland JM, Wilson SJ, et al. Antimicrobial use control measures to prevent and control. Antimicrobial resistance in US hospitals [ J]. Infect Control Hosp Epidemiol,2006 ; 27 : 1088 - 1095.
  • 9Meyer E,Schwab F,Gastmeier P,et al. Surveillance of antimicrobial use and antimicrobial resistance in german intensive care units (SARI) :A summary of the data from 2001 through 2004 [ J ]. Infection, 2006 ; 34 : 303 - 309.
  • 10Mahamat A, Lavigne JP, Fabbro - Peray P, et al. Evolution of fluo- roquinolone resistance among Escherichia coll. urinary tract isolates from a French university hospital: application of the dynamic regression model [ J ]. Clin Microbiol Infect,2005 ; 11:301 - 306.

共引文献43

同被引文献32

  • 1唐玉梅,陈解语,陈晓宇,荣延平.门诊处方抗菌药物应用调查分析[J].中国感染控制杂志,2006,5(3):231-233. 被引量:18
  • 2葛文再.我院抗菌药物不合理处方分析[J].中国药物滥用防治杂志,2006,12(3):171-172. 被引量:13
  • 3李景苏,蔡长春,侯艳宁.我院抗菌药物临床应用调查分析[J].中国药房,2007,18(29):2267-2269. 被引量:26
  • 4Antoniadou A, Kanellakopoulou K, Kanellopoulou M, et al. Im- pact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative baeteria[J]. Seand J Infect Dis, 2013,45 ( 6 ) : 438-445.
  • 5Cao J, Song W, Gu B, et al. Correlation between carbapenem con- sumption and antimicrobial resistance rates of acinetobacter bau- mannii in a university-affiliated hospital in China[J]. J Clin Phar- macol, 2013,53( 1 ) :96-102.
  • 6Aldeyab MA, Harbarth S, Vernaz N, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary health- care settings [ J ]. Br J Clin Pharmacol, 2012,74 ( 1 ) : 171-179.
  • 7Velickovic-Radovanovic R, Petrovic J, Kocic B, et al. Analysis of antibiotic utilization and bacterial resistance changes in a surgicalclinic of Clinical Centre, Ni[J]. J Clin Pharm Ther, 2012, 37(1) :32-36.
  • 8Moreira MR, Guimaraes MP, Rodrigues AA, et al. Antimicrobial use, incidence, etiology and resistance patterns in bacteria causing ventilator-associated pneumonia in a clinical-surgical intensive care unit[ J]. Rev Soc Bras Med Trop, 2013,46( 1 ) :39-44.
  • 9Diacon AH, Donald PR, Pym A, et al. Randomized pilot trial of eight weeks of bedaquilinc ( TMC207 ) treatment for multidrug-re- sistant tuberculosis: long-term outcome, tolcrability, and effect on emergence of drug resistance[ J]. Antimicrob agents and chemoth- er, 2012,56(6) :3271-3276.
  • 10Hoban DJ, Bouchillon SK, Hawser SP, et al. Trends in the fre- quency of multiple drug-resistant Enterobacteriaceae and their sus- ceptibility to ertapenem, imipenem, and other antimicrobial a- gents : data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007[J]. Diagn Mierobiol and Infect Dis, 2010, 66( 1 ) :78-86.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部